IBB · iShares

iShares Biotechnology ETF

See how 246 reported holdings combine into this ETF’s P/E and P/S. Market value, signed ordinary earnings and revenue are added before each ratio is calculated.

Holdings dated 19 August 2026Price US$205.29 as of 2 October 2026Coverage limitations apply

Core valuation

Trailing P/E-89.01×95.56% coverage

Latest-quarter run-rate P/E-38.07×95.56% coverage

Trailing P/S7.43×84.24% coverage

Latest-quarter run-rate P/S6.97×83.70% coverage

Coverage is the share of positive eligible-equity holding value represented in each metric. The published holdings account for 100.00% of fund weight. The reliability standard requires at least 90.00% disclosed fund weight and metric coverage, with no individual uncovered holding above 1.00%.

Largest reported holdings

Largest reported ETF holdings with weights and trailing valuation ratios
Holding	Weight	Trailing P/E	Trailing P/S
AMGNAMGEN INC	8.40%	25.18×	5.78×
VRTXVERTEX PHARMACEUTICALS	7.89%	29.16×	10.20×
GILDGILEAD SCIENCES INC	7.02%	-56.45×	6.00×
REGNREGENERON PHARMACEUTICALS	5.81%	17.99×	5.01×
MRNAMODERNA INC	4.34%	-23.94×	33.86×
ARGXARGENX SE ADR	3.68%	38.91×	12.18×
NTRANATERA	3.04%	-306.11×	21.75×
RVMDREVOLUTION MEDICINES	2.80%	-24.96×	Unavailable
BIIBBIOGEN	2.22%	23.98×	3.31×
ALNYALNYLAM PHARMACEUTICALS	2.21%	39.93×	6.44×

Top 10 of 246 reported holdings. * A holding uses its latest full-year result only when both trailing and latest-quarter inputs are unavailable; open the stock for the exact year end.

Most similar funds

Ranked by shared weight across matching disclosed company holdings and explicitly reported same-currency cash.

BBH · VanEck Biotech ETF60.61% holdings overlap · Nasdaq
XBI · State Street SPDR S&P Biotech ETF41.42% holdings overlap · NYSE Arca
FBT · First Trust NYSE Arca Biotechnology Index Fund39.23% holdings overlap · NYSE Arca
BMED · iShares Health Innovation Active ETF34.38% holdings overlap · NYSE Arca
FTXH · First Trust Nasdaq Pharmaceuticals ETF34.08% holdings overlap · Nasdaq

Sources and limitations

Holdings are sourced from iShares and company financial inputs retain primary-source links. Monetary values are normalised to USD. Corporate actions, reporting lags, unmapped securities and cash can create differences from provider figures.

Open official holdings source

Research holdings date: 19 August 2026. Informational research, not investment advice.